These forward-looking statements involve certain risks and uncertainties. This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). The Company’s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T‑cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors. More information about Adaptimmune’s R&D leaders can be found here on the Leadership Team page.Īdaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer.
The Pipeline Research team will continue to be led by Karen Miller, SVP Pipeline Research. Joanna Brewer has been promoted to SVP, Allogeneic Research and will continue leading the allogeneic discovery work. Dennis has been promoted to SVP, Late Stage Development and will continue leading the regulatory affairs team. The first of these trials is SPEARHEAD-1 with ADP-A2M4 – currently open for recruitment of patients with synovial sarcoma or myxoid/round cell liposarcoma. A Late Stage Development group, led by Dennis Williams, will take products through Phase 2/3 trials and registration. Mark becomes Senior Vice President (SVP), Early Stage Development and previously served as SVP, Product Development. An Early Stage Development group, led by Mark Dudley, will evaluate therapies in Phase 1 studies for safety as well as determining their potential for efficacy and further clinical development. He performed his residency in Internal Medicine at Temple University Hospital, Philadelphia and GI fellowship at Thomas Jefferson University Hospital, Philadelphia.Ĭhanges to the R&D Leadership that will strengthen the end-to-end scientific and clinical development from early to late stage, include: Norry practiced adult internal medicine at Abington Memorial Hospital in Abington, Pennsylvania for 13 years. Prior to his work in the biotech and pharmaceutical industries, Dr. Prior to joining Adaptimmune, he served as Safety Development Leader and was Chair of the Hepatic Safety Panel at GSK. He has been acting Chief Medical Officer since August 2019. Norry has served as Head of Clinical Safety and Pharmacovigilance and leader of the ADP-A2AFP program since 2015. “In addition, we have made changes to our R&D leadership to accelerate how our products move from research to late stage development, including rapid application of translational learnings that are crucial to bringing cell therapies to patients.”ĭr. I look forward to continuing to work with Elliot to deliver cell therapy treatments to patients with cancer,” said Adrian Rawcliffe, Adaptimmune’s Chief Executive Officer. This builds on his impact leading the ADP-A2AFP program in liver cancer as well as leading our safety and pharmacovigilance team over the last four years. “Elliot has done a fantastic job as acting CMO over the past few months. Elliot Norry as Senior Vice President and Chief Medical Officer (CMO) effective immediately, and additional changes to its R&D organization. 13, 2020 (GLOBE NEWSWIRE) - Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, today announced the appointment of Dr. Please allow ushers to assist with seating to ensure maximized spacing.PHILADELPHIA and OXFORDSHIRE, United Kingdom, Jan. Patrons must provide a vaccine card and photo identification, and wear a mask. GOOD TO KNOW: Genesis Theatre follows all indoor event PHO safety protocols. 
Produced by The Delta Stageworks Artist Collective TICKETS AVAILABLE ONLY ONLINE BY GENERAL ADMISSIONįeaturing: Cameron Bancroft, Renee Iaci, Eric Keenleyside, Peg Keenleyside, Marilyn Norry, Sandra Patterson and (on Zoom) Vera Mayor, Lorne Patterson, Nick Keenleyside and Sam Bob
From community interviews, local news events and the exploration of our own lived experiences of living through the monumental changes of this last year and a half, comes a multimedia theatrical evening of stories that follow the ups and downs, the laughs and the lows of the lockdown life we've all been experiencing since March 2020.
#NORRY CAD PROFESSIONAL#
A devised-theatre project created over the course of a year by the Delta Stageworks artist collective featuring a cast of both professional artists and community members. THEN & NOW, Pandemic Life Stories - A Staged Reading at Genesis Theatre, in Ladner, BC. THEN & NOW, Pandemic Life Stories - a devised-theatre project tracing the highs and the lows of lockdown life over the past 18 months.
0 kommentar(er)
